Other
Deferred Taxes
West Pharmaceutical Services Deferred Taxes decreased by 1.3% to $22.70M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 6.6%, from $21.30M to $22.70M. Over 5 years (FY 2020 to FY 2025), Deferred Taxes shows an upward trend with a 17.2% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ4 2024
Last reportedQ1 2026
How to read this metric
An increase suggests the company is deferring tax payments, which can improve current cash flow, while a decrease indicates the settlement of these deferred obligations.
Detailed definition
This represents the amount of income taxes payable in future periods as a result of temporary differences between the ca...
Peer comparison
Standard across all industries; levels are driven by capital expenditure cycles and depreciation methods.
Metric ID:
other_deferred_income_tax_liabilities_netHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $12.20M | $11.60M | $4.90M | $3.30M | $1.20M | $16.60M | $14.30M | $14.50M | $15.40M | $16.50M | $12.70M | $12.70M | $13.70M | $9.40M | $20.50M | $21.30M | $23.00M | $22.80M | $23.00M | $22.70M |
| QoQ Change | — | -4.9% | -57.8% | -32.7% | -63.6% | >999% | -13.9% | +1.4% | +6.2% | +7.1% | -23.0% | +0.0% | +7.9% | -31.4% | +118.1% | +3.9% | +8.0% | -0.9% | +0.9% | -1.3% |
| YoY Change | — | — | — | — | -90.2% | +43.1% | +191.8% | +339.4% | >999% | -0.6% | -11.2% | -12.4% | -11.0% | -43.0% | +61.4% | +67.7% | +67.9% | +142.6% | +12.2% | +6.6% |
Range$1.20M – $23.00M
CAGR+14.0%
Avg YoY Growth+121.7%
Median YoY Growth+27.6%
Deferred Taxes at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's deferred taxes?
- West Pharmaceutical Services (WST) reported deferred taxes of $22.70M in Q1 2026.
- How has West Pharmaceutical Services's deferred taxes changed year-over-year?
- West Pharmaceutical Services's deferred taxes increased by 6.6% year-over-year, from $21.30M to $22.70M.
- What is the long-term trend for West Pharmaceutical Services's deferred taxes?
- Over 5 years (2020 to 2025), West Pharmaceutical Services's deferred taxes has grown at a 17.2% compound annual growth rate (CAGR), from $10.40M to $23.00M.
- What does deferred taxes mean?
- Future tax payments the company expects to make due to timing differences in accounting.